Peer review reports
From: Impact of antiviral treatment on long-term prognosis in non-immunocompromised patients with CMV reactivation
Original Submission |
12 Jan 2021 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
9 Feb 2021 |
Reviewed |
Reviewer Report
|
14 Mar 2021 |
Reviewed |
Reviewer Report
|
5 Apr 2021 |
Author responded |
Author comments - Jae-Hoon Ko
|
Resubmission - Version 4 |
5 Apr 2021 |
Submitted |
Manuscript version 4
|
6 Apr 2021 |
Author responded |
Author comments - Jae-Hoon Ko
|
Resubmission - Version 5 |
6 Apr 2021 |
Submitted |
Manuscript version 5
|
12 Apr 2021 |
Reviewed |
Reviewer Report
|
18 Apr 2021 |
Reviewed |
Reviewer Report
|
Resubmission - Version 6 |
|
Submitted |
Manuscript version 6
|
Publishing |
19 Apr 2021 |
Editorially accepted |
|
4 May 2021 |
Article published |
10.1186/s12879-021-06098-4
|
Learn about peer review